Startseite Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3
Artikel
Lizenziert
Nicht lizenziert Erfordert eine Authentifizierung

Limb girdle muscular dystrophy in a sibling pair with a homozygous Ser606Leu mutation in the alternatively spliced IS2 region of calpain 3

  • Dieter E. Jenne , Rudi A. Kley , Matthias Vorgerd , J. Michael Schröder , Joachim Weis , Heike Reimann , Beate Albrecht , Peter Nürnberg , Holger Thiele , Clemens R. Müller , Gerhard Meng , Christian C. Witt und Siegfried Labeit
Veröffentlicht/Copyright: 1. Juni 2005
Biological Chemistry
Aus der Zeitschrift Band 386 Heft 1

Abstract

Previous family studies revealed a large number of calpain 3 (CAPN3) mutations that cause recessive forms of limb girdle muscular dystrophy (LGMD2A) with selective atrophy of the proximal limb muscles. Correlations between the nature and site of a particular mutation and its corresponding phenotype, however, can only be established from homozygous mutations, which are particularly rare in the alternatively spliced NS, IS1 and IS2 regions of CAPN3. Here we identified a sibling pair with LGMD2A-type muscular dystrophy caused by a homozygous Ser606Leu (S606L) substitution in the IS2 linker domain. Normal protein levels, unaltered myofibrillar targeting and conserved calcium-induced autocatalytic activity of the mutated protein could be demonstrated in muscle biopsies from one patient. Despite this inconspicuous modification of the IS2 linker between domains III and IV, both patients developed signs and symptoms of the disease within their second decade of life. The unexpected severity of the clinical manifestation points to the high relevance of the calpain 3-specific IS2 segment between domains III and IV. We conclude that the structural motif around the Ser606 residue represents an important functional site that may regulate the transient activation and limited proteolysis of calpain 3.

:

Corresponding author

References

Alexa, A., Bozoky, Z., Farkas, A., Tompa, P., and Friedrich, P. (2004). Contribution of distinct structural elements to activation of calpain by Ca2+ ions. J. Biol. Chem.279, 20118–20126.10.1074/jbc.M311969200Suche in Google Scholar

de Paula, F., Vainzof, M., Passos-Bueno, M.R., de Cassia, M.P., Matioli, S.R., Anderson, V.B., Nigro, V., and Zatz, M. (2002). Clinical variability in calpainopathy: what makes the difference?Eur. J. Hum. Genet.10, 825–832.10.1038/sj.ejhg.5200888Suche in Google Scholar

Dib, C., Faure, S., Fizames, C., Samson, D., Drouot, N., Vignal, A., Millasseau, P., Marc, S., Hazan, J., Seboun, E., et al. (1996). A comprehensive genetic map of the human genome based on 5264 microsatellites. Nature380, 152–154.10.1038/380152a0Suche in Google Scholar

Fanin, M., Nascimbeni, A.C., Fulizio, L., Trevisan, C.P., Meznaric-Petrusa, M., and Angelini, C. (2003). Loss of calpain-3 autocatalytic activity in LGMD2A patients with normal protein expression. Am. J. Pathol.163, 1929–1936.10.1016/S0002-9440(10)63551-1Suche in Google Scholar

Fanin, M., Fulizio, L., Nascimbeni, A.C., Spinazzi, M., Piluso, G., Ventriglia, V.M., Ruzza, G., Siciliano, G., Trevisan, C.P., Politano, L. et al. (2004). Molecular diagnosis in LGMD2A: mutation analysis or protein testing?Hum. Mutat.24, 52–62.10.1002/humu.20058Suche in Google Scholar

Fukiage, C., Nakajima, E., Ma, H., Azuma, M., and Shearer, T.R. (2002). Characterization and regulation of lens-specific calpain Lp82. J. Biol. Chem.277, 20678–20685.10.1074/jbc.M200697200Suche in Google Scholar

Herasse, M., Ono, Y., Fougerousse, F., Kimura, E., Stockholm, D., Beley, C., Montarras, D., Pinset, C., Sorimachi, H., Suzuki, K., et al. (1999). Expression and functional characteristics of calpain 3 isoforms generated through tissue-specific transcriptional and posttranscriptional events. Mol. Cell. Biol.19, 4047–4055.10.1128/MCB.19.6.4047Suche in Google Scholar

Jia, Z., Petrounevitch, V., Wong, A., Moldoveanu, T., Davies, P.L., Elce, J.S., and Beckmann, J.S. (2001). Mutations in calpain 3 associated with limb girdle muscular dystrophy: analysis by molecular modeling and by mutation in m-calpain. Biophys. J.80, 2590–2596.10.1016/S0006-3495(01)76229-7Suche in Google Scholar

Kramerova, I., Kudryashova, E., Tidball, J.G., and Spencer, M.J. (2004). Null mutation of calpain 3 (p94) in mice causes abnormal sarcomere formation in vivo and in vitro. Hum. Mol. Genet.13, 1373–1388.10.1093/hmg/ddh153Suche in Google Scholar

Kruglyak, L., Daly, M.J., Reeve Daly, M.P., and Lander, E.S. (1996). Parametric and nonparametric linkage analysis: aunified multipoint approach. Am. J. Hum. Genet.58, 1347–1363.Suche in Google Scholar

Nakajima, T., Fukiage, C., Azuma, M., Ma, H., and Shearer, T.R. (2001). Different expression patterns for ubiquitous calpains and Capn3 splice variants in monkey ocular tissues. Biochim. Biophys. Acta1519, 55–64.10.1016/S0167-4781(01)00212-3Suche in Google Scholar

Ono, Y., Shimada, H., Sorimachi, H., Richard, I., Saido, T.C., Beckmann, J.S., Ishiura, S., and Suzuki, K. (1998). Functional defects of a muscle-specific calpain, p94, caused by mutations associated with limb-girdle muscular dystrophy type 2A. J. Biol. Chem.273, 17073–17078.10.1074/jbc.273.27.17073Suche in Google Scholar

Ono, Y., Sorimachi, H., and Suzuki, K. (1999). New aspect of the research on limb-girdle muscular dystrophy 2A: a molecular biologic and biochemical approach to pathology. Trends Cardiovasc. Med.9, 114–118.10.1016/S1050-1738(99)00018-3Suche in Google Scholar

Reverter, D., Sorimachi, H., and Bode, W. (2001). The structure of calcium-free human m-calpain: implications for calcium activation and function. Trends Cardiovasc. Med.11, 222–229.10.1016/S1050-1738(01)00112-8Suche in Google Scholar

Richard, I., Broux, O., Allamand, V., Fougerousse, F., Chiannilkulchai, N., Bourg, N., Brenguier, L., Devaud, C., Pasturaud, P., Roudaut, C. et al. (1995). Mutations in the proteolytic enzyme calpain-3 cause limb-girdle muscular-dystrophy type-2A. Cell81, 27–40.10.1016/0092-8674(95)90368-2Suche in Google Scholar

Richard, I., Brenguier, L., Dincer, P., Roudaut, C., Bady, B., Burgunder, J.M., Chemaly, R., Garcia, C.A., Halaby, G., Jackson, C.E. et al. (1997). Multiple independent molecular etiology for limb-girdle muscular dystrophy type 2A patients fromvarious geographical origins. Am. J. Hum. Genet.60, 1128–1138.Suche in Google Scholar

Richard, I., Roudaut, C., Saenz, A., Pogue, R., Grimbergen, J.E.M.A., Anderson, L.V.B., Beley, C., Cobo, A.M., de Diego, C., Eymard, B. et al. (1999). Calpainopathy – a survey of mutations and polymorphisms. Am. J. Hum. Genet.64, 1524–1540.10.1086/302426Suche in Google Scholar PubMed PubMed Central

Sorimachi, H., Kinbara, K., Kimura, S., Takahashi, M., Ishiura, S., Sasagawa, N., Sorimachi, N., Shimada, H., Tagawa, K., Maruyama, K., and Suzuki, K. (1995). Muscle-specific calpain, p94, responsible for limb girdle muscular dystrophy type 2A, associates with connectin through IS2, a p94-specific sequence. J. Biol. Chem.270, 31158–31162.10.1074/jbc.270.52.31158Suche in Google Scholar PubMed

Witt, C.C., Ono, Y., Puschmann, E., McNabb, M., Wu, Y., Gotthardt, M., Witt, S.H., Haak, M., Labeit, D., Gregorio, C.C., et al. (2004). Induction and myofibrillar targeting of CARP, and suppression of the Nkx2.5 pathway in the MDM mouse with impaired titin-based signaling. J. Mol. Biol.336, 145–154.Suche in Google Scholar

Published Online: 2005-06-01
Published in Print: 2005-01-01

©2004 by Walter de Gruyter Berlin New York

Heruntergeladen am 18.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/BC.2005.008/html
Button zum nach oben scrollen